← Back to Search

Photochromic Contact Lens

Light-Adaptive Contact Lenses for Visual Impairment

N/A
Recruiting
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Experience glare and light sensitivity that impacts patient's daily living activities
Have confirmed diagnosis of ocular condition including but not limited to Stargardt's, Cone dystrophy, Cone-rod dystrophy, Albinism, Retinitis Pigmentosa and Achromatopsia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure change from baseline at the 6 week follow-up visit
Awards & highlights

Study Summary

This trial tested whether contact lenses with special technology can ease visual issues for people with vision problems.

Who is the study for?
This trial is for individuals who experience glare and light sensitivity due to conditions like Stargardt's, Cone dystrophy, or Albinism. Participants must be impacted in their daily activities by these issues, able to wear contact lenses, give informed consent, and understand English. Pregnant individuals or those with recent eye infections or surgeries are excluded.Check my eligibility
What is being tested?
The study is testing Acuvue Oasys with Transitions contact lenses to see if they can improve visual comfort by reducing glare and light sensitivity for people with visual impairments.See study design
What are the potential side effects?
While the specific side effects aren't listed here, typical contact lens use may cause discomfort, dry eyes, redness or potential infection especially if not used as instructed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience glare and light sensitivity that affects my daily activities.
Select...
I have a diagnosed eye condition like Stargardt's or Retinitis Pigmentosa.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure change from baseline at the 6 week follow-up visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and measure change from baseline at the 6 week follow-up visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glare test
Secondary outcome measures
Visual Activities Questionnaire on Glare and Light sensitivity visual functions

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment groupExperimental Treatment1 Intervention
All participants will be fit with Acuvue Oasys with Transitions.

Find a Location

Who is running the clinical trial?

Nova Southeastern UniversityLead Sponsor
89 Previous Clinical Trials
11,625 Total Patients Enrolled
American Academy of OptometryOTHER
3 Previous Clinical Trials
176 Total Patients Enrolled
So Yeon Lee, ODStudy ChairNova Southeastern University

Media Library

Acuvue Oasys with Transitions (Photochromic Contact Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05829135 — N/A
Visual Impairment Research Study Groups: Treatment group
Visual Impairment Clinical Trial 2023: Acuvue Oasys with Transitions Highlights & Side Effects. Trial Name: NCT05829135 — N/A
Acuvue Oasys with Transitions (Photochromic Contact Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05829135 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit imposed on participation in this experiment?

"According to the inclusion criteria, individuals that are between 18 and 64 years old may be eligible for this medical study."

Answered by AI

Am I eligible to join this medical research project?

"Eligibility for this clinical trial necessitates that patients have photophobia and are between 18 and 64 years old. 16 individuals will be chosen to participate in the study."

Answered by AI

Is this experimentation in need of additional participants at present?

"Affirmative. According to the clinicaltrials.gov, this experiment is currently recruiting participants; it was posted on May 1st 2023 and updated most recently on April 12th of the same year. The research requires 16 volunteers from a single medical centre."

Answered by AI

How many participants have been recruited to this research effort?

"Affirmative. The data presented on clinicaltrials.gov reveals that this medical experiment is actively recruiting participants. It was initially advertised on May 1st 2023 and most recently updated April 12th of the same year, with a total requirement for 16 patients from one study site."

Answered by AI
~0 spots leftby May 2024